JENNIFER MCKEE: Open Payments
NPI 1841758059 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$73,947 in 90 payments from 24 companies in 2025. Trend: 2023 $887 · 2024 $849 · 2025 $73,947
Debt forgiveness: $72,482Food & beverage: $1,464
| Company | Payments | Amount |
|---|---|---|
| ConvaTec Inc. | 12 | $72,482 |
| Ardelyx, Inc. | 10 | $202 |
| Novo Nordisk Inc | 9 | $149 |
| GlaxoSmithKline, LLC. | 8 | $146 |
| AstraZeneca Pharmaceuticals LP | 7 | $138 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $121 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $73 |
| ABBVIE INC. | 4 | $66 |
Products named: INNOVAMATRIX AC, IBSRELA, TRELEGY ELLIPTA, Kerendia, Ozempic, FARXIGA, CAPLYTA, XIFAXAN.
Industry payments across TN — which companies pay providers there.
